ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,905Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 978

$678K Total Retail Price of All Prescriptions

Rank: 19 out of 978

445 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

26% of this provider’s 445 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

18% of this provider’s 445 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 9,501 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
AMLODIPINE BESYLATE 456 376 1 6
SIMVASTATIN 410 293 2 2
LISINOPRIL 409 236 3 1
FUROSEMIDE 400 356 4 9
OMEPRAZOLE 365 220 5 3
WARFARIN SODIUM 281 239 6 11
METOPROLOL TARTRATE 249 203 7 10
TRAZODONE HCL 214 176 8 18
LEVOTHYROXINE SODIUM 206 162 9 4
ATENOLOL 204 165 10 8
HYDROCODONE-ACETAMINOPHEN 198 99 S3 11 17
METFORMIN HCL 194 114 12 7
CITALOPRAM HBR 188 158 13 14
ALENDRONATE SODIUM 185 172 14 20
SERTRALINE HCL 181 144 15 21
HYDROCHLOROTHIAZIDE 171 153 16 5
CRESTOR 168 122 17 30
GLIMEPIRIDE 159 119 18 63
DONEPEZIL HCL 157 157 19 26
PRAVASTATIN SODIUM 156 124 20 16
GABAPENTIN 153 91 21 15
OXYCODONE-ACETAMINOPHEN 146 64 S2 22 25
MORPHINE SULFATE ER 144 63 S2 23 71
ATORVASTATIN CALCIUM 144 114 23 12
METOPROLOL SUCCINATE 132 104 25 13
QUETIAPINE FUMARATE 128 56 26 51
POTASSIUM CHLORIDE 117 117 27 41
TRAMADOL HCL 111 73 28 24
MELOXICAM 110 87 29 112
OXYCODONE HCL 108 28 S2 30 23
PANTOPRAZOLE SODIUM 103 75 31 39
NAMENDA 93 93 32 45
TAMSULOSIN HCL 92 74 33 33
LOSARTAN POTASSIUM 88 76 34 22
PAROXETINE HCL 87 65 35 52
RANITIDINE HCL 86 85 36 27
PROAIR HFA 85 40 37 19
ZOLPIDEM TARTRATE 84 34 38 32
RISPERIDONE 83 76 39 49
LACTULOSE 81 58 40 92
ALLOPURINOL 80 72 41 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 71 42 36
ADVAIR DISKUS 78 75 42 35
VESICARE 77 68 44 157
PREDNISONE 77 67 44 47
SPIRIVA 73 49 46 37
ZETIA 73 48 46 109
FENTANYL 72 30 S2 48 85
METFORMIN HCL ER 68 61 49 48
CARVEDILOL 65 36 50 55
MIRTAZAPINE 65 54 50 31
DILTIAZEM 24HR CD 64 64 52 111
LEVETIRACETAM 62 43 53 93
DILTIAZEM 24HR ER 62 55 53 69
CYCLOBENZAPRINE HCL 60 16 R 55 62
VENLAFAXINE HCL 60 42 55 201
DETROL LA 59 54 57 153
ACETAMINOPHEN-CODEINE 57 40 S3 58 102
FLUTICASONE PROPIONATE 57 39 58 28
OXYCODONE HCL-ACETAMINOPHEN 57 22 S2 58 78
KLOR-CON M20 55 49 61 66
ONGLYZA 55 30 61 216
PHENYTOIN SODIUM EXTENDED 55 20 61 147
MORPHINE SULFATE 54 21 S2 64 163
CLOPIDOGREL 54 42 64 61
LANTUS 54 49 64 40
ISOSORBIDE MONONITRATE ER 52 42 67 57
NEXIUM 52 32 67 77
FINASTERIDE 51 44 69 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.